Considering the continuous complexity of the global challenges , the United Nations has proposed a series of Sustainable Development Goals (SDGs) which aimed at promoting these issues of urgency by 2030. Here we utilize our iGEM project as an example to explore how synthetic biology contributes to these goals, as well as showing the results we have achieved.
Our Solution:In this project, we developed a immune-targeted therapy by the use of SynBio missiles to treat oral squamous cell carcinoma. Our work has a direct effect on SDG3. The goal of promoting Good health and well-being can be considered as the primary aim of our project, which focuses on treating oral squamous cell carcinoma. Malignant tumors are among the most challenging disease types in treatment, however current therapies rely individually on surgical removal and chemotherapy, both of which have severe side effects. To be short, we aim to ignite a beacon of hope in the dark and challenging world of oral cancer.
We aim to develop a gene-recombinant SynBio missile targeting therapy as a new hope for oral squamous cell carcinoma. Thus, we hope to spark a glimmer of hope in the hearts of oral malignancy patients around the world, enabling them to return to normal life, freeing them from the suffering of the disease and the endless burden of high drug treatment costs, thereby alleviating their economic and social burdens.
Specific Goal 2: With the development of a new therapy for oral squamous cell carcinoma, anyone who needs it will have access to it. Moreover, due to the highly selective nature of this approach which targets only cancer cells without harming normal ones, patients would have shorter rehabilitation time and better quality of lives. This result will be significant to patients, especially to those living in remote areas with limited medical resources, allowing patients to receive treatment at home and reducing their reliance on medical institutions.
Associate Professor of Oral Oncology, MD. Wencai Ma is an experienced oncologist in Lanzhou, who have been working in this field for over 20 years. He has published numerous works on oral tumors, including five articles in SCI journals.
We introduced our project to Dr. Wencai Ma from various perspectives, including the human practice aspect. Dr. Ma show keen interest to our project. He discussed the immune-targeted therapy we designed, highly praising the effective specificity and selectivity, which would provide additional efficacy to our treatment. He also noted that our project is very meaningful to the promotion of the treatment of oral cancer.
Lei Wang is a talented young doctor with great enthusiasm and extensive expertise in oral oncology. He expressed concerns about the potential harm that the immune-targeted therapy, specifically the SynBio missile, might cause to normal cells. In response, we explained the mechanism of the SynBio missile and validated that our therapy is safe. By the end of this interview, he express a high degree of recognition.
We value feedback from young doctors like Lei Wang because we believe that such experiences are not the only way to gain knowledge; they can also stem from a passion for innovation and creativity. This is why we reached out to Dr. Lei Wang, as he is eager to continue the search for new therapies for oral malignancies.
Our project aims to provide a new treatment solution for patients with oral squamous cell carcinoma. This will help comprehensively to improve patients' physical health and overall well-being, alleviate their physical burdens, and reduce pain caused by oral cancer as well as other chronic diseases. This will give them a better opportunity to go back to work and daily activities more easily and effectively without encountering any obstacles. Therefore, it can promote more productive employment and better economic growth by maintaining a healthy workforce.
If this project is realizable and further developed, our team will work towards establishing a biopharmaceutical innovation platform centered around Lanzhou University, collaborating with research institutions, enterprises, and incubators both within and out of Lanzhou and even Gansu Province. This platform will support new drug research and development, technology transfer, and business incubation, becoming a key driver of technological innovation in the region and promoting the development of the biopharmaceutical industry chain.
During our visit to the Lanzhou Maternal and Child Health Hospital, we interviewed the head of the hospital's logistics department and several employees. We briefly introduced our project, and then conducted a survey regarding their understanding of oral squamous cell carcinoma. The results indicated that some employees have chronic illnesses or other diseases to varying degrees, and some of their colleagues have been diagnosed with cancer and need to accept current treatment. However, they could not drop their jobs, and their illnesses decreased their work efficiency, while prolonged labor further impacts their health.
To confirm whether there is a genuine direct relationship between our project and SDG 8, we aimed to reach out to individuals whose careers and income sources have been severely affected by malignant tumors. Therefore, we decided to visit the Lanzhou High-tech Zone Community Elderly Service Center and communicate with the elderly there. During the visit, we met an older man who shared the story since he had been diagnosed with oral squamous cell carcinoma (OSCC) three years ago. He recounted how OSCC had ruined his career and plunged his family into debt.
He also described the current surgical treatments as a contributing factor to his situation, as the surgery left him unable to speak and made him reluctant to go out and engage social activities. This negatively affected his work efficiency, since he could no longer handle his job well. Ultimately, he told us that if he had been able to access our treatment methods the first time he was diagnosed with it, it could have saved his career and have a significant impact on his future. He further noted that our therapy could help more people to reduce the risk of losing dignified employment due to disabilities caused by OSCC and similar conditions. As he preferred not to be photographed, we have not included any images of him from our interview.
Dr. Qian Wu is a physician at Gansu Provincial People’s Hospital. We introduced our team and project to her, in which she showed great interest and admired our initiative. She noted that there are many drawbacks in current traditional therapies. if this project is realizable, it would be a significant achievement. Finally, she pointed out that we should pay more attention to the product's half-life, which will serve as an important source of inspiration for further advancing our project in the future.
Our immunotherapy targeting SynBio missile will have significant long-term social effects, as oral tumors affect the lives of numerous patients by limiting their social interactions, leading to social isolation, impacting their emotional health, and diminishing their productivity in various aspects of life. Through our treatment, patients will be able to return to work, freely engage in social activities and improve their emotional well-being.
The potential long-term economic impact of our treatment will be clear and effective, as all current treatment options come with after effects and shortages, which trap patients in an endless cycle of expensive medications. This becomes a lifelong economic burden for both the patients and the government, while our treatment is a one-time intervention. By receiving our therapy, patients will gain lifelong protection from the disease and can avoid substantial expenses related to surgeries and medical services associated with the illness.
Our project may have significant potential long-term environmental impacts, as our therapy will reduce the use of prescription medications and radiation therapy. Prescription drugs require many environmental resources, such as water, energy and chemicals. Additionally, the disposal of these medications can pose a substantial threat to the environment. Therefore, our project conserves resources used for prescription drugs and does not pose any environmental threat.
Goal 3: Good Health and Well-Being
Oral malignant tumors are diseases that severely affect patients' quality of life. This project can improve the lives of tens of thousands of patients by providing innovative treatment solutions through SynBio missile therapy, enabling them to return to normal daily life without pain.
Goal 8: Decent Work and Economic Growth
Malignant tumors reduce worker productivity and increase healthcare costs, which directly impacts the economy. Our project enables workers to perform normally without worrying about their illness, and it will lower healthcare costs, ultimately alleviating the overall economic burden of oral malignant tumors.
Goal 9: Industry, Innovation, and Infrastructure
We are developing a new therapy that uses genetically modified bacteria to treat oral malignant tumors. Our project will revolutionize the treatment of oral malignant tumors and take a leading role, potentially guiding the development of new therapies for other malignant tumors. Our project also helps to build medical infrastructure by training scientists and researchers in synthetic biology and biotechnology.
Goal 10: Reduce Inequality
Patients with oral malignant tumors often suffer from facial deformities post-surgery. Our palliative treatment projects contribute to reducing inequality.
Goal 17: Partnerships for The Goals
We collaborated with HBUT-China and LZU-MEDICINE-CHINA teams to write an SDG manual. This manual provides guidance for future teams wishing to explore sustainable development to achieve SDG 17 (strengthening the means of implementation and revitalizing the global partnership for sustainable development). We clarified the significance and importance of the SDGs in the manual, as well as the contributions made by various countries towards achieving them.
Here are some specific suggestions for future iGEM teams regarding Sustainable Development Goals (SDGs):
1.Emphasize Sustainability
2.Community Engagement
3.Interdisciplinary Collaboration
4.Education and Advocacy
5.Develop Long-Term Strategies
6.Technological Innovation
7.International Perspective
8.Continuous Improvement
We participated in the annual orientation lecture for new medical students. We discussed SynBio and the iGEM competition, talking about the Sustainable Development Goals and showcasing our GSLZ-A 2024 SDGs-related materials to familiarize them with the SDGs, as most were not well acquainted with this terminology. We discussed the importance of the SDGs and how they addressed the most pressing challenges facing the world today. The Sustainable Development Goals are universal and applicable to all countries, aiming to create a better future for everyone. We also discussed the impact of our project on the SDGs and shared experiences on how to guide future projects to maximize their impact on the Sustainable Development Goals.
This project is not only an attempt at technological innovation but also a positive effort to promote the United Nations Sustainable Development Goals (SDGs). Through school and community health education, field visits, and workshops, our team’s project can provide tangible benefits for patients with oral squamous cell carcinoma while raising public awareness of the Sustainable Development Goals.
In the future, our team will continue to focus on translating research outcomes into social value, contributing to health, industrial innovation, and the reduction of inequalities. With solid planning and action, we are sure to become leaders in global health and sustainable development.
1.World Health Organization - official website
2.Maity, Shrabanti, and Anup Sinha. 2024. “Disparities in Achieving SDG Goal of ‘No Poverty’ for Developing Countries: Technical Efficiency Estimates across Asian, African and American Nations.” International Journal of Sustainable Development & World Ecology, July, 1–14. doi:10.1080/13504509.2024.2377247.
3.World Health Organization - Cardiovascular diseases
4. Delanka-Pedige, H. M. K., Munasinghe-Arachchige, S. P., Abeysiriwardana-Arachchige, I. S. A., & Nirmalakhandan, N. (2020). Wastewater infrastructure for sustainable cities: assessment based on UN sustainable development goals (SDGs). International Journal of Sustainable Development & World Ecology, 28(3), 203–209. https://doi.org/10.1080/13504509.2020.1795006
5.World Health Organization - news - fact-sheets - diabetes
6.Bali Swain, R., & Yang-Wallentin, F. (2019). Achieving sustainable development goals: predicaments and strategies. International Journal of Sustainable Development & World Ecology, 27(2), 96–106. https://doi.org/10.1080/13504509.2019.1692316
7..World Health Organization - news - facts-in-pictures - diabetes